General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Camilleri M et al. – Pharmacokinetics studies showed dose proportionality in health, and no significant differences between health and chronic constipation with a 15 mg oral dose of Velusetrag. Stimulation of bowel function after15 mg Velusetrag was similar in CC and controls. There were no serious adverse events; notable adverse events were the predictable gastrointestinal effects such as diarrhoea or altered bowel movements. Velusetrag significantly accelerated intestinal and colonic transit after single dosing and accelerated gastric emptying after multiple dosing.

Today in GI Motility...keeping you current

Rumination or belching–regurgitation? Differential diagnosis using oesophageal impedance–manometry
Neurogastroenterology and Motility, 12/03/09

Small intestinal disorders in the elderly
Best Practice & Research Clinical Gastroenterology , 12/02/09

Endoscopic Appearance of the Minor Papilla Predicts Findings at Pancreatography
Digestive Diseases and Sciences, 11/23/09

Today in Small/Large Intestine...keeping you current

A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis
Journal of Pediatric Surgery, 12/04/09

Deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease
Alimentary Pharmacology and Therapeutics, 12/04/09

Patients' views of medical positioning for proctologic examination
Clinical and Experimental Gastroenterology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address